SARS-CoV-2-IN-14

MedChem Express

SARS-CoV-2-IN-14

10

Research Use Only

99.02

C13H9Cl2NO2

282.12

SARS-CoV-2-IN-14 (compound 6) is a potent inhibitor of SARS-CoV-2 with an IC50 of 0.39 microM. SARS-CoV-2-IN-14 is a niclosamide analogue. SARS-CoV-2-IN-14 contains higher stability in human plasma and liver S9 enzymes assay than niclosamide, which can improve bioavailability and half-life when administered orally[1].

O=C(C1=C(C=CC(Cl)=C1)O)NC2=CC(Cl)=CC=C2

-20°C,2°C to 8°C

12352200